Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Infacort Sprinkles in Healthy Adult Males
NCT03178214Phase 1Completed
- Sponsor
- Neurocrine Biosciences
- Start
- May 2017
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of hydrocortisone in adrenal insufficiency (AI) (3 arms), sponsored by Neurocrine Biosciences. Primary endpoints: Area under the curve from time zero to time t at 12 hours, Area under the curve from time zero to infinity at 12 hours and 1 more. Started May 2017; status: completed.
02
Drugs
hydrocortisone
03
Conditions
adrenal insufficiency (AI)
Beyond the preview
Go deeper on NCT03178214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03178214.